NDC 0025-1911
CALAN SR
Verapamil Hydrochloride
CALAN SR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by G.d. Searle Llc Division Of Pfizer Inc. The primary component is Verapamil Hydrochloride.
Product ID | 0025-1911_1fdc5551-f2b1-403d-b265-902cc9cb225f |
NDC | 0025-1911 |
Product Type | Human Prescription Drug |
Proprietary Name | CALAN SR |
Generic Name | Verapamil Hydrochloride |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 1989-12-15 |
Marketing Category | NDA / NDA |
Application Number | NDA019152 |
Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Active Ingredient Strength | 180 mg/1 |
Pharm Classes | P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |